Mansfield, MA -- July 28, 2004 - Axeda Systems Inc. (Nasdaq: XEDA), the world's leading provider of device relationship management (DRM) software and services, today announced that Wako Pure Chemical Industries, Ltd., the leading supplier of life science reagents in Japan, has licensed the Axeda® DRM™ system to enable proactive customer support of its LiBASys clinical blood auto-analyzer.

The LiBASys clinical instrument is an automated liquid-phase binding immunoassay analyzer based on liquid phase-binding assay (LBA) principles. It is designed to diagnose early recognition of liver diseases.

"By utilizing Axeda's DRM technology, we will be able to provide our customers with the capability to run their LiBASys analyzers at optimum, avoiding costly delays of device failure, lowering cost of operation, and maximizing customer satisfaction," said Tonya Mallory, executive manager, Diagnostics, Wako Chemical USA. "DRM provides outstanding visibility of occurrences at the system level, allowing us to better serve our customers with features such as proactive scheduling of service resources based on customer need, automated re-supply capability that is fully integrated with the Company's billing system, and 24x7 visibility into current and historical system performance data."

"We are very pleased that Wako Pure Chemical has selected the Axeda DRM system to enable the remote management and monitoring of the LiBASys analyzer," stated Dale Calder, co-founder and president of Axeda Systems. "Wako Pure Chemical joins other leading medical device manufacturers that are benefiting from providing Axeda's remote service solution to its customers, leveraging Axeda's patented Firewall-Friendly™ technology. We are also very excited to have added Wako Pure Chemical to our growing list of customers for Axeda's hosted services offering."

The Axeda DRM™ system is a distributed software system that securely transmits status and usage data via the Internet from remote equipment to service representatives, alerting them if a device is operating outside of preset performance standards. Axeda's patented Firewall-Friendly™ technology utilizes the public Internet to enable secure communication within medical facilities. These and other features enable life sciences companies to comply with regulations protecting patient information including 21 CFR Part 11 and HIPAA.

About Wako
Wako Pure Chemical Industries, Ltd. ( www.wako-chem.co.jp ), is the leading supplier of life science reagents in Japan. Founded in 1922, the company distributes both its own products as well as those of other foreign and domestic manufacturers.

About Axeda®
Axeda Systems Inc. (NASDAQ: XEDA) is the world's leading provider of device relationship management (DRM) software and services. Our flagship product, the Axeda DRM System™ helps manufacturing and service organizations increase revenue while lowering costs by proactively monitoring and managing devices deployed at customer sites around the world. Axeda DRM® leverages patented Firewall-Friendly™ technology that utilizes the public Internet to enable Machine-to-Machine (M2M) communication. It is the most scalable, field-proven, and comprehensive remote management solution available on the market today. Axeda customers include Global 2000 companies in multiple markets including Medical Instrumentation, Enterprise Technology, Industrial and Building Automation, Office Automation, and Semiconductor Equipment industries. Axeda has sales and service offices in the U.S., Europe, and Japan, and distribution partners worldwide. More information about Axeda is available at www.axeda.com.

Press Contact:
Erin Nolan Smith
Corporate
+1 508-718-6351
enolan@axeda.com